Volume 29, Number 9—September 2023
Dispatch
Prevalence of Asymptomatic Mpox among Men Who Have Sex with Men, Japan, January–March 2023
Table
Case no. | Classification | HIV status | Sample type | Ct value | Timeframe, d |
Symptoms | ||||
---|---|---|---|---|---|---|---|---|---|---|
Sexual activity to diagnosis | Sexual activity to symptom onset | Negative test to symptom onset | Symptom onset to diagnosis | Negative test to diagnosis | ||||||
1 | Asymptomatic | On PrEP | Anorectal swab | 21.2 | 10 | NA | NA | NA | NA | NA |
2 | Asymptomatic | HIV | Pooled† | 20.8 | 29 | NA | NA | NA | NA | NA |
3 | Asymptomatic | On PrEP | Pooled† | 28.4 | ND | NA | NA | NA | NA | NA |
4 | Symptomatic‡ | HIV | Pooled† | 28.8 | 8 | 11 | NA | NA | NA | Skin lesions |
5 | Symptomatic§ | On PrEP | Pooled† | 31.0 | 48 | 8 | NA | NA | NA | Fever and pharyngitis |
6 | Symptomatic¶ | HIV | Skin lesion swab | ND | 22 | 15 | 32 | 7 | 39 | Skin lesions |
7 | Symptomatic¶ | On PrEP | Skin lesion swab | ND | 23 | 18 | 48 | 5 | 53 | Skin lesions, fever, lymphadenopathy, and pharyngitis |
8 | Symptomatic¶ | On PrEP | Skin lesion swab | ND | 18 | 9 | 13 | 9 | 22 | Skin lesions, fever, lymphadenopathy, and pharyngitis |
9 | Symptomatic¶ | HIV | Skin lesion swab | ND | 8 | 4 | 53 | 4 | 57 | Skin lesions and lymphadenopathy |
*Ct, cycle threshold; NA, not applicable; ND, no data; PrEP, preexposure prophylaxis. †Samples consisted of anorectal swabs, initial stream urine, and gargle rinse. ‡Initially asymptomatic but had symptoms develop during study. §Initially asymptomatic, but patient later reported previous self-resolving symptoms. ¶Initially tested negative but had symptoms develop during study.
1These authors contributed equally to this article.
Page created: July 21, 2023
Page updated: August 20, 2023
Page reviewed: August 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.